These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11694653)

  • 21. Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: evidence for estrogen receptor mediation.
    Li SA; Weroha SJ; Tawfik O; Li JJ
    J Endocrinol; 2002 Nov; 175(2):297-305. PubMed ID: 12429028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological and molecular bases of mammary carcinogenesis.
    Russo J; Russo IH
    Lab Invest; 1987 Aug; 57(2):112-37. PubMed ID: 3302534
    [No Abstract]   [Full Text] [Related]  

  • 23. Sex hormone-induced mammary carcinogenesis in the female Noble rats: expression of bcl-2 and bax in hormonal mammary carcinogenesis.
    Xie B; Tsao SW; Wong YC
    Breast Cancer Res Treat; 2000 May; 61(1):45-57. PubMed ID: 10930089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soy isoflavone exposure through all life stages accelerates 17β-estradiol-induced mammary tumor onset and growth, yet reduces tumor burden, in ACI rats.
    Möller FJ; Pemp D; Soukup ST; Wende K; Zhang X; Zierau O; Muders MH; Bosland MC; Kulling SE; Lehmann L; Vollmer G
    Arch Toxicol; 2016 Aug; 90(8):1907-16. PubMed ID: 26861028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antioxidant butylated hydroxyanisole inhibits estrogen-induced breast carcinogenesis in female ACI rats.
    Singh B; Mense SM; Remotti F; Liu X; Bhat HK
    J Biochem Mol Toxicol; 2009; 23(3):202-11. PubMed ID: 19526586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Partial inhibition of estrogen-induced mammary carcinogenesis in rats by tamoxifen: balance between oxidant stress and estrogen responsiveness.
    Singh B; Bhat NK; Bhat HK
    PLoS One; 2011; 6(9):e25125. PubMed ID: 21966433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of three genetic determinants of susceptibility to estrogen-induced mammary cancer within the Emca8 locus on rat chromosome 5.
    Schaffer BS; Leland-Wavrin KM; Kurz SG; Colletti JA; Seiler NL; Warren CL; Shull JD
    Cancer Prev Res (Phila); 2013 Jan; 6(1):59-69. PubMed ID: 23151807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure.
    Mense SM; Remotti F; Bhan A; Singh B; El-Tamer M; Hei TK; Bhat HK
    Toxicol Appl Pharmacol; 2008 Oct; 232(1):78-85. PubMed ID: 18640140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Timing of dietary fat exposure and mammary tumorigenesis: role of estrogen receptor and protein kinase C activity.
    Hilakivi-Clarke L; Clarke R
    Mol Cell Biochem; 1998 Nov; 188(1-2):5-12. PubMed ID: 9823005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolomic analysis uncovered an association of serum phospholipid levels with estrogen-induced mammary tumors in female ACI/Seg rats.
    Okamoto Y; Aoki A; Ueda K; Jinno H
    Toxicol Lett; 2018 May; 288():65-70. PubMed ID: 29454887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary tocopherols inhibit cell proliferation, regulate expression of ERα, PPARγ, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia.
    Smolarek AK; So JY; Thomas PE; Lee HJ; Paul S; Dombrowski A; Wang CX; Saw CL; Khor TO; Kong AN; Reuhl K; Lee MJ; Yang CS; Suh N
    Mol Carcinog; 2013 Jul; 52(7):514-25. PubMed ID: 22389237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of six genetic determinants of susceptibility to estrogen-induced mammary cancer in the rat and assessment of their relevance to breast cancer risk in humans.
    Colletti JA; Leland-Wavrin KM; Kurz SG; Hickman MP; Seiler NL; Samanas NB; Eckert QA; Dennison KL; Ding L; Schaffer BS; Shull JD
    G3 (Bethesda); 2014 May; 4(8):1385-94. PubMed ID: 24875630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA 'signature' during estrogen-mediated mammary carcinogenesis and its reversal by ellagic acid intervention.
    Munagala R; Aqil F; Vadhanam MV; Gupta RC
    Cancer Lett; 2013 Oct; 339(2):175-84. PubMed ID: 23791885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tocopherols inhibit oxidative and nitrosative stress in estrogen-induced early mammary hyperplasia in ACI rats.
    Das Gupta S; So JY; Wall B; Wahler J; Smolarek AK; Sae-Tan S; Soewono KY; Yu H; Lee MJ; Thomas PE; Yang CS; Suh N
    Mol Carcinog; 2015 Sep; 54(9):916-25. PubMed ID: 24782330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis.
    Singh B; Ronghe AM; Chatterjee A; Bhat NK; Bhat HK
    Carcinogenesis; 2013 May; 34(5):1165-72. PubMed ID: 23492819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats.
    Blank EW; Wong PY; Lakshmanaswamy R; Guzman R; Nandi S
    Proc Natl Acad Sci U S A; 2008 Mar; 105(9):3527-32. PubMed ID: 18299580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic control of estrogen action in the rat: mapping of QTLs that impact pituitary lactotroph hyperplasia in a BN x ACI intercross.
    Shull JD; Lachel CM; Murrin CR; Pennington KL; Schaffer BS; Strecker TE; Gould KA
    Mamm Genome; 2007 Sep; 18(9):657-69. PubMed ID: 17876666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naturally-occurring estradiol-17beta-fatty acid esters, but not estradiol-17beta, preferentially induce mammary tumorigenesis in female rats: implications for an important role in human breast cancer.
    Mills LH; Yu J; Xu XM; Lee AJ; Zhu BT
    Toxicol Appl Pharmacol; 2008 Jun; 229(3):332-41. PubMed ID: 18394671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cumin Prevents 17β-Estradiol-Associated Breast Cancer in ACI Rats.
    Aqil F; Jeyabalan J; Munagala R; Ahmad I; Schultz DJ; Gupta RC
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estradiol metabolism: an endocrine biomarker for modulation of human mammary carcinogenesis.
    Telang NT; Katdare M; Bradlow HL; Osborne MP
    Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):559-64. PubMed ID: 9167995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.